On paper, you can generate a lot of value, that is true.” He said.
But it makes more sense to him to stay independent. It increases the competition, even if the offices are only located a few kilometers away.
Let’s say it’s more of an artificial competition between two biotechs than a real one, just enough to create a sensation of company identity and belonging. However, the perceived competition is more founded for employees, partners and providers outside Switzerland, who continue to see Roche and Novartis as two entirely different biotech companies.
The research and business strategies of both also differ.